**Core Concept**
Metoclopramide, a dopamine antagonist, is used as an antiemetic to prevent nausea and vomiting. Its action is primarily mediated through the blockade of dopamine receptors in the chemoreceptor trigger zone (CTZ) of the brain and the gastrointestinal tract.

**Why the Correct Answer is Right**
Metoclopramide's antiemetic effect is mainly due to its action as a dopamine D2 receptor antagonist. By blocking these receptors in the CTZ, metoclopramide inhibits the vomiting reflex initiated by the chemoreceptor trigger zone. Additionally, its action in the gastrointestinal tract as a dopamine antagonist enhances gastric motility and prevents gastric stasis, further contributing to its antiemetic effect.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because metoclopramide's action as a serotonin 5-HT4 receptor agonist primarily enhances gastrointestinal motility and is not its main mechanism of antiemetic action.
**Option B:** This option is incorrect because metoclopramide does not primarily act as a muscarinic receptor agonist; its antiemetic effect is not mediated through this mechanism.
**Option C:** This option is incorrect because metoclopramide's action as a histamine H1 receptor antagonist is not its main mechanism of antiemetic action; it is more relevant to its antihistaminic properties.

**Clinical Pearl / High-Yield Fact**
Metoclopramide's antiemetic effect is most effective when used in combination with other antiemetic agents, such as ondansetron or dexamethasone, to prevent chemotherapy-induced nausea and vomiting.

**Correct Answer: C. Dopamine D2 receptor antagonist.**